conference reporter

Conference Reporter in Liver Fibrosis to Cover Key Topics Being Presented at Recent Liver Disease Meeting

Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. This issue of Conference Reporter will feature coverage of selected topics in Liver Fibrosis presented at a recent Liver Disease meeting. 

The clinicians who were surveyed selected the following expert commentators and topics from the upcoming conference.

Community-Selected Expert Commentators: 

Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD

Professor, Elson S. Floyd College of Medicine
Washington State University
Director, Liver Institute Northwest
Seattle, WA

Rohit Loomba, MD, MHSc

Director, NAFLD Research Center
Professor of Medicine, Director of Hepatology, and Vice Chief
Division of Gastroenterology
Adjunct Professor, Division of Epidemiology
University of California, San Diego
San Diego, CA

Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD

Transplant Hepatologist and Chief of Clinical Research Affairs
Avera Transplant Institute, Sioux Falls, SD
Professor of Medicine and Director, Hepatology Course
University of South Dakota Sanford School of Medicine
Vermillion, SD


Community-Selected Topics: 

    Multidisciplinary Care for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Noninvasive Testing for Differing Phenotypes
    Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Precision Medicine in Evaluation and Treatment
    Novel Approaches to Detect Liver Disease
    Pharmacotherapy for Nonalcoholic Steatohepatitis: Clinical Trials and Therapies on the Horizon
    The Gut-Liver Axis and the Microbiome in Liver Inflammation, Fibrosis


This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Association for the Study of Liver Diseases. 

More in Liver Fibrosis

Thumb

Liver Fibrosis

Noninvasive Tests to Risk Stratify Patients With Fatty Liver Disease

Conference Reporter by Rohit Loomba, MD, MHSc

Biopsy remains the gold standard for diagnosing nonalcoholic steatohepatitis (NASH). However, the great need for noninvasive tests to risk stratify...READ MORE

Thumb

Liver Fibrosis

Therapies on the Horizon for Nonalcoholic Steatohepatitis

Conference Reporter by Rohit Loomba, MD, MHSc

Agents in development to treat nonalcoholic steatohepatitis (NASH) are beginning to be tested in phase 3 clinical trials, suggesting that treatment...READ MORE

Thumb

Liver Fibrosis

Novel Approaches to Detect Liver Disease

Conference Reporter by Ashwani K. Singal, MD, MS, AGAF, FACG, FAASLD

Recent data on novel approaches for detecting liver disease were presented at The Liver MeetingĀ® 2021. Ashwani K. Singal, MD, MS, AGAF, FACG, FAASL...READ MORE